This Rapid Recap will provide a responsive, timely, and incisive overview of data presented at the 2022 Clinical Oncology Annual Meeting, and offer expert insights into the shifting management landscape for metastatic EGFR+ NSCLC.
Thoracic Medical Oncology Group, Princess Margaret Cancer Centre,
Professor, Department of Medicine,
Adjunct Professor, Institute of Health Policy Management and Evaluation,
University of Toronto, Toronto, ON, Canada
Lung Cancer Medical Oncologist
Memorial Sloan Kettering Cancer Center
New York, NY
Lung Cancer Patient and Advocate
Chair, IASLC Patient Advocacy Committee
Co-Founder EGFR Resisters
Deerfield Park, IL
All clinicians managing patients with non-dialysis-dependent chronic kidney disease or heart failure must be aware of the deleterious impacts of concomitant anemia and the established, emerging, and practice-changing role of intravenous (IV) iron therapies.
President, Baylor Scott and White Research Institute, Dallas, TX
Distinguished Professor of Medicine
University of Mississippi, Jackson, MS
Director, Division of Nephrology
Professor of Medicine
University of Maryland Medical System
Baltimore, MD
Join our Expert Faculty, Drs. Joel W. Neal, MD, PhD and Victoria Sherry, DNP, CRNP, AOCNP as they discuss treatment principles across the continuum of care in unresectable, stage III NSCLC.
Associate Professor of Medicine, Division of Oncology
Medical Director for the Cancer Clinical Trials Office
Medical Director of Informatics Stanford Cancer Center Stanford, CA
Oncology Nurse Practitioner for Thoracic Malignancies
Abramson Cancer Center
Philadelphia, PA
To facilitate timely diagnosis and rapid treatment initiation for anemia in CKD, the multidisciplinary and interprofessional CKD-anemia treatment team should be aware of the significant impact of anemia on patient quality of life, progression of CKD, and cardiovascular events.
Clinical Associate Professor and Vice Chair for Research
Department of Pharmacy Practice
School of Pharmacy and Pharmaceutical Sciences
University at Buffalo, Buffalo, NY
Nephrology
University of Alabama at Birmingham
Birmingham, AL
Senior Associate Dean for Postgraduate Medical Education
Director, Master in Medical Sciences in Clinical Investigation (MMSCI) program, Harvard Medical School
Physician, Renal Division
Brigham and Women’s Hospital/ Dana Farber Cancer Institute, Boston, MA
This dynamic live symposium, led by top experts in the field of pulmonary medicine and NSCLC, will take attendees on a deep dive into the sentinel role of the pulmonologist in the NSCLC management paradigm, exploring adaptive mechanisms to optimize collaborative strategies in a patient centric manner.
Lung Cancer Patient and Advocate
Chair, IASLC Patient Advocacy Committee
Co-Founder EGFR Resisters
Deerfield Park, IL
Director, Multidisciplinary Thoracic Oncology Program
George C. and Margaret M. Hillenbrand Endowed Chair
Professor, Division of Pulmonary, Critical Care, Allergy and Sleep Medicine
Medical University of South Carolina, Charleston
Medical Director, UF Shands Medical Intensive Care Unit
Division Vice-Chief for Medical Affairs
Program Director, Interventional Pulmonology Fellowship Program
University of Florida Health, Gainesville, FL
Harvard Medical School
Brigham and Women’s Hospital
Boston, MA
